MoonLake is a Switzerland-based clinical-stage biopharmaceutical company that provides sonelokimab, the novel investigational nanobody for the treatment of inflammation.
Business Model:
Revenue: $0
Employees: 11-50
Address: Untermuli 7
City: Zug
State: shiselweni
Zip: 6302
Country: SZ
MoonLake is a Switzerland-based clinical-stage biopharmaceutical company that provides sonelokimab, the novel investigational nanobody for the treatment of inflammation.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
4/6/2022
IPO Valuation:
$620M
Ticker Symbol:
MLTX
Amount Raised:
$230M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2022 | Post-IPO Equity | 9 | $115M |
653 Investment Partners Asymmetry Capital Management BVF Partners Cormorant Asset Management Ghost Tree Capital Group Monashee Investment Management RTW Investments LLC Surveyor Capital Tekla Capital Management 683 CAPITAL 653 Investment Partners Asymmetry Capital Management BVF Partners Cormorant Asset Management Ghost Tree Capital Group Monashee Investment Management RTW Investments LLC Surveyor Capital Tekla Capital Management |
5/2021 | Series A | - | 4/2022 | IPO | - |
|
5/2021 | Series A | - |
BVF Partners LP BVF Partners LP |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|